Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses
Jv Lazarus
(1, 2)
,
K Safreed-Harmon
(2)
,
Sr Stumo
(2)
,
Marie Jauffret-Roustide
(3)
,
M Maticic
(4)
,
T Reic
,
E Schatz
,
J Tallada
,
M Harris
(5)
1
UCPH -
University of Copenhagen = Københavns Universitet
2 ISGlobal - Instituto de Salud Global - Institute For Global Health [Barcelona]
3 CERMES3 - UMR 8211 / U988 / UM 7 - CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société
4 UMCL - University Medical Centre Ljubljana [Ljubljana, Slovenia]
5 LSHTM - London School of Hygiene and Tropical Medicine
2 ISGlobal - Instituto de Salud Global - Institute For Global Health [Barcelona]
3 CERMES3 - UMR 8211 / U988 / UM 7 - CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société
4 UMCL - University Medical Centre Ljubljana [Ljubljana, Slovenia]
5 LSHTM - London School of Hygiene and Tropical Medicine